AZN.L - AstraZeneca PLC

LSE - LSE Delayed Price. Currency in GBp
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue23,002,00024,708,00026,547,00025,806,000
Cost of Revenue3,996,0004,460,0005,735,0005,135,000
Gross Profit19,006,00020,248,00020,812,00020,671,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses19,255,00020,609,00022,344,00018,964,000
Operating Income or Loss3,747,0004,099,0004,203,0006,842,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes3,747,0004,099,0004,203,0006,842,000
Interest Expense-617,000-392,000-418,000-413,000
Income Before Tax----
Income Tax Expense146,000243,00011,000696,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income3,499,0002,825,0001,233,0002,556,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----